Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 10.85
+0.03 (0.28%)
Aug 29, 2025, 11:30 AM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
Pharmaceutical Distribution | 2.69B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Distribution Growth | -29.27% | Log In | Log In | Log In | Log In | Upgrade |
Anti-Infective Drugs | 1.88B | Log In | Log In | Log In | Log In | Upgrade |
Anti-Infective Drugs Growth | 8.87% | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular Drugs | 1.34B | Log In | Log In | Log In | Log In | Upgrade |
Cardiovascular Drugs Growth | -0.88% | Log In | Log In | Log In | Log In | Upgrade |
Antineoplastic Drugs | 973.34M | Log In | Log In | Log In | Log In | Upgrade |
Antineoplastic Drugs Growth | 14.34% | Log In | Log In | Log In | Log In | Upgrade |
Imported Pharmaceutical Preparations and Outsourced Pharmaceutical Marketing | 822.40M | Log In | Log In | Log In | Log In | Upgrade |
Imported Pharmaceutical Preparations and Outsourced Pharmaceutical Marketing Growth | 28.15% | Log In | Log In | Log In | Log In | Upgrade |
Anti-parasitic and Veterinary Drugs | 713.45M | Log In | Log In | Log In | Log In | Upgrade |
Anti-parasitic and Veterinary Drugs Growth | -14.07% | Log In | Log In | Log In | Log In | Upgrade |
Other Drugs | 621.98M | Log In | Log In | Log In | Log In | Upgrade |
Other Drugs Growth | 8.62% | Log In | Log In | Log In | Log In | Upgrade |
Endocrine Drugs | 510.33M | Log In | Log In | Log In | Log In | Upgrade |
Endocrine Drugs Growth | 48.59% | Log In | Log In | Log In | Log In | Upgrade |
Other Business | 215.22M | Log In | Log In | Log In | Log In | Upgrade |
Other Business Growth | -0.14% | Log In | Log In | Log In | Log In | Upgrade |
Other | 16.90M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | -50.93% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
China | 8.98B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -4.47% | Log In | Log In | Log In | Log In | Upgrade |
Foreign | 594.27M | Log In | Log In | Log In | Log In | Upgrade |
Foreign Growth | -21.84% | Log In | Log In | Log In | Log In | Upgrade |